{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:38:34Z","timestamp":1794857914347,"version":"4.9.1"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41574-019-0224-4","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T08:03:11Z","timestamp":1560844991000},"page":"601-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":299,"title":["Turner syndrome: mechanisms and\u00a0management"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-1720","authenticated-orcid":false,"given":"Claus H.","family":"Gravholt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6574-4893","authenticated-orcid":false,"given":"Mette H.","family":"Viuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-2949","authenticated-orcid":false,"given":"Sara","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstine","family":"Stochholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5394-3016","authenticated-orcid":false,"given":"Niels H.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,18]]},"reference":[{"key":"224_CR1","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0430","volume":"177","author":"CH Gravholt","year":"2017","unstructured":"Gravholt, C. H. et al. Clinical practice guidelines for the\u00a0care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur. J. Endocrinol. 177, G1\u2013G70 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"224_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00402166","volume":"38","author":"NC Lonberg","year":"1977","unstructured":"Lonberg, N. C. & Nielsen, J. Seresevskij-Turner\u2019s syndrome or Turner\u2019s syndrome [letter]. Hum. Genet. 38, 363\u2013364 (1977).","journal-title":"Hum. Genet."},{"key":"224_CR3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2265.2007.02807.x","volume":"66","author":"M El-Mansoury","year":"2007","unstructured":"El-Mansoury, M. et al. Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clin. Endocrinol. 66, 744\u2013751 (2007).","journal-title":"Clin. Endocrinol."},{"key":"224_CR4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/cen.13394","volume":"87","author":"A Cameron-Pimblett","year":"2017","unstructured":"Cameron-Pimblett, A., La, R. C., King, T. F. J., Davies, M. C. & Conway, G. S. The Turner Syndrome Life Course Project: karyotype-phenotype analyses across the lifespan. Clin. Endocrinol. 87, 532\u2013538 (2017).","journal-title":"Clin. Endocrinol."},{"key":"224_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng0597-54","volume":"16","author":"E Rao","year":"1997","unstructured":"Rao, E. et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat. Genet. 16, 54\u201363 (1997).","journal-title":"Nat. Genet."},{"key":"224_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000444596","volume":"7","author":"M Fukami","year":"2016","unstructured":"Fukami, M., Seki, A. & Ogata, T. SHOX haploinsufficiency as a cause of syndromic and nonsyndromic short stature. Mol. Syndromol. 7, 3\u201311\u00a0(2016).","journal-title":"Mol. Syndromol."},{"key":"224_CR7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2016-1036","volume":"37","author":"A Marchini","year":"2016","unstructured":"Marchini, A., Ogata, T. & Rappold, G. A. A. Track record on SHOX: from basic research to complex models and therapy. Endocr. Rev. 37, 417\u2013448 (2016).","journal-title":"Endocr. Rev."},{"key":"224_CR8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007692","volume":"14","author":"H Corbitt","year":"2018","unstructured":"Corbitt, H. et al. TIMP3 and TIMP1 are risk genes for bicuspid aortic valve and aortopathy in Turner syndrome. PLOS Genet. 14, e1007692 (2018).","journal-title":"PLOS Genet."},{"key":"224_CR9","doi-asserted-by":"crossref","DOI":"10.1038\/srep34220","volume":"6","author":"C Trolle","year":"2016","unstructured":"Trolle, C. et al. Widespread DNA hypomethylation and differential gene expression in Turner syndrome. Sci. Rep. 6, 34220 (2016).","journal-title":"Sci. Rep."},{"key":"224_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/bs.pmbts.2017.02.002","volume":"147","author":"SW Rabkin","year":"2017","unstructured":"Rabkin, S. W. The role matrix metalloproteinases in the production of aortic aneurysm. Prog. Mol. Biol. Transl Sci. 147, 239\u2013265 (2017).","journal-title":"Prog. Mol. Biol. Transl Sci."},{"key":"224_CR11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13148-015-0112-2","volume":"7","author":"A Sharma","year":"2015","unstructured":"Sharma, A. et al. DNA methylation signature in peripheral blood reveals distinct characteristics of\u00a0human X chromosome numerical aberrations. Clin.\u00a0Epigenet. 7, 76 (2015).","journal-title":"Clin. Epigenet."},{"key":"224_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100076","volume":"9","author":"SN Rajpathak","year":"2014","unstructured":"Rajpathak, S. N. et al. Human 45,X fibroblast transcriptome reveals distinct differentially expressed genes including long noncoding RNAs potentially associated with the pathophysiology of Turner syndrome. PLOS ONE 9, e100076 (2014).","journal-title":"PLOS ONE"},{"issue":"Suppl. 5","key":"224_CR13","volume":"14","author":"R Zhang","year":"2013","unstructured":"Zhang, R. et al. Gene expression analysis of induced pluripotent stem cells from aneuploid chromosomal syndromes. BMC Genomics 14 (Suppl. 5), 8 (2013).","journal-title":"BMC Genomics"},{"key":"224_CR14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/ng0793-268","volume":"4","author":"M Watanabe","year":"1993","unstructured":"Watanabe, M., Zinn, A. R., Page, D. C. & Nishimoto, T. Functional equivalence of human X- and Y-encoded isoforms of ribosomal protein S4 consistent with a role in Turner syndrome. Nat. Genet. 4, 268\u2013271 (1993).","journal-title":"Nat. Genet."},{"key":"224_CR15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1101\/gr.230433.117","volume":"28","author":"S Naqvi","year":"2018","unstructured":"Naqvi, S., Bellott, D. W., Lin, K. S. & Page, D. C. Conserved microRNA targeting reveals preexisting gene dosage sensitivities that shaped amniote sex chromosome evolution. Genome Res. 28, 474\u2013483 (2018).","journal-title":"Genome Res."},{"key":"224_CR16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature13206","volume":"508","author":"DW Bellott","year":"2014","unstructured":"Bellott, D. W. et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature 508, 494\u2013499 (2014).","journal-title":"Nature"},{"key":"224_CR17","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1073\/pnas.1116763109","volume":"109","author":"E Pessia","year":"2012","unstructured":"Pessia, E., Makino, T., Bailly-Bechet, M., McLysaght, A. & Marais, G. A. Mammalian X chromosome inactivation evolved as a dosage-compensation mechanism for dosage-sensitive genes on the X\u00a0chromosome. Proc. Natl Acad. Sci. USA 109, 5346\u20135351 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"224_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.semcdb.2018.07.013","volume":"90","author":"F Yan","year":"2018","unstructured":"Yan, F., Wang, X. & Zeng, Y. 3D genomic regulation of lncRNA and Xist in X chromosome. Semin. Cell Dev. Biol. 90, 174\u2013180 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"224_CR19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/humu.22229","volume":"34","author":"N Miyake","year":"2013","unstructured":"Miyake, N. et al. KDM6A point mutations cause Kabuki syndrome. Hum. Mutat. 34, 108\u2013110 (2013).","journal-title":"Hum. Mutat."},{"key":"224_CR20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31780-0","volume":"8","author":"A Skakkebaek","year":"2018","unstructured":"Skakkebaek, A. et al. DNA hypermethylation and differential gene expression associated with Klinefelter syndrome. Sci. Rep. 8, 13740 (2018).","journal-title":"Sci. Rep."},{"key":"224_CR21","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1073\/pnas.1802889115","volume":"115","author":"A Raznahan","year":"2018","unstructured":"Raznahan, A. et al. Sex-chromosome dosage effects on gene expression in humans. Proc. Natl Acad. Sci. USA 115, 7398\u20137403 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"224_CR22","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1002\/ajmg.a.37953","volume":"170","author":"SK Prakash","year":"2016","unstructured":"Prakash, S. K. et al. Autosomal and X chromosome structural variants are associated with congenital heart defects in Turner syndrome: the NHLBI GenTAC registry. Am. J. Med. Genet. A 170, 3157\u20133164 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"224_CR23","doi-asserted-by":"crossref","first-page":"A538","DOI":"10.1016\/j.autrev.2011.11.015","volume":"11","author":"A Lleo","year":"2012","unstructured":"Lleo, A., Moroni, L., Caliari, L. & Invernizzi, P. Autoimmunity and Turner\u2019s syndrome. Autoimmun. Rev. 11, A538\u2013A543 (2012).","journal-title":"Autoimmun. Rev."},{"key":"224_CR24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cei.13231","volume":"195","author":"A Berglund","year":"2018","unstructured":"Berglund, A. et al. 21-hydroxylase autoantibodies are\u00a0more prevalent in Turner syndrome but without an\u00a0association to the autoimmune polyendocrine syndrome type I. Clin. Exp. Immunol. 195, 364\u2013368 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"224_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004175","volume":"4","author":"A Urbach","year":"2009","unstructured":"Urbach, A. & Benvenisty, N. Studying early lethality of\u00a045,XO (Turner\u2019s syndrome) embryos using human embryonic stem cells. PLOS ONE 4, e4175 (2009).","journal-title":"PLOS ONE"},{"key":"224_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0168-9525(86)90194-0","volume":"2","author":"TJ Hassold","year":"1986","unstructured":"Hassold, T. J. Chromosome abnormalities in human reproductive wastage. Trends. Genet. 2, 105\u2013110 (1986).","journal-title":"Trends. Genet."},{"key":"224_CR27","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2006-0558","volume":"91","author":"K Stochholm","year":"2006","unstructured":"Stochholm, K., Juul, S., Juel, K., Naeraa, R. W. & Gravholt, C. H. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J. Clin. Endocrinol. Metab. 91, 3897\u20133902 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR28","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0976-2","volume":"14","author":"A Berglund","year":"2019","unstructured":"Berglund, A. et al. Changes in the cohort composition of Turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: a nationwide cohort study. Orphanet J. Rare Dis. 14, 16 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"224_CR29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41436-018-0271-6","volume":"21","author":"MA Tuke","year":"2018","unstructured":"Tuke, M. A. et al. Mosaic Turner syndrome shows reduced penetrance in an adult population study. Genet. Med. 21, 877\u2013886 (2018).","journal-title":"Genet. Med."},{"key":"224_CR30","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/humrep\/dev192","volume":"30","author":"MH Viuff","year":"2015","unstructured":"Viuff, M. H. et al. Only a minority of sex chromosome abnormalities are detected by the Danish national prenatal screening program for Down syndrome. Hum.\u00a0Reprod. 30, 2419\u20132426 (2015).","journal-title":"Hum. Reprod."},{"key":"224_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajmg.c.31675","volume":"181","author":"DW Bianchi","year":"2019","unstructured":"Bianchi, D. W. Turner syndrome: new insights from prenatal genomics and transcriptomics. Am. J. Med. Genet. C 181, 29\u201333 (2019).","journal-title":"Am. J. Med. Genet. C"},{"key":"224_CR32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/gim.0b013e31822e57a7","volume":"14","author":"KC Jeon","year":"2012","unstructured":"Jeon, K. C., Chen, L. S. & Goodson, P. Decision to abort after a prenatal diagnosis of sex chromosome abnormality: a systematic review of the literature. Genet. Med. 14, 27\u201338 (2012).","journal-title":"Genet. Med."},{"key":"224_CR33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0895-4356(97)00237-0","volume":"51","author":"CH Gravholt","year":"1998","unstructured":"Gravholt, C. H., Juul, S., Naeraa, R. W. & Hansen, J. Morbidity in Turner syndrome. J. Clin. Epidemiol. 51, 147\u2013158 (1998).","journal-title":"J. Clin. Epidemiol."},{"key":"224_CR34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/er.2011-1059","volume":"33","author":"KH Mortensen","year":"2012","unstructured":"Mortensen, K. H., Andersen, N. H. & Gravholt, C. H. Cardiovascular phenotype in Turner syndrome \u2014integrating cardiology, genetics, and endocrinology. Endocr. Rev. 33, 677\u2013714 (2012).","journal-title":"Endocr. Rev."},{"key":"224_CR35","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1210\/jc.2008-1049","volume":"93","author":"MJ Schoemaker","year":"2008","unstructured":"Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F. & Jacobs, P. A. Mortality in women with Turner syndrome in Great Britain: a national cohort study. J. Clin. Endocrinol. Metab. 93, 4735\u20134742 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR36","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1530\/EJE-11-1066","volume":"166","author":"K Stochholm","year":"2012","unstructured":"Stochholm, K. et al. Socio-economic parameters and mortality in Turner syndrome. Eur. J. Endocrinol. 166, 1013\u20131019 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"224_CR37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(08)70033-0","volume":"9","author":"MJ Schoemaker","year":"2008","unstructured":"Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F. & Jacobs, P. A. Cancer incidence in women with Turner syndrome in Britain: a national cohort study. Lancet Oncol. 9, 239\u2013246 (2008).","journal-title":"Lancet Oncol."},{"key":"224_CR38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ijc.30126","volume":"139","author":"J Ji","year":"2016","unstructured":"Ji, J., Zoller, B., Sundquist, J. & Sundquist, K. Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: a national cohort study. Int. J. Cancer. 139, 754\u2013758 (2016).","journal-title":"Int. J. Cancer."},{"key":"224_CR39","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMc062795","volume":"355","author":"P Bosze","year":"2006","unstructured":"Bosze, P., Toth, A. & Torok, M. Hormone replacement and the risk of breast cancer in Turner\u2019s syndrome. N.\u00a0Engl. J. Med. 355, 2599\u20132600 (2006).","journal-title":"N. Engl. J. Med."},{"key":"224_CR40","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/jc.2016-2046","volume":"102","author":"AJ Swerdlow","year":"2017","unstructured":"Swerdlow, A. J. et al. Cancer risks in patients treated with growth hormone in childhood: the SAGhE European Cohort Study. J. Clin. Endocrinol. Metab. 102, 1661\u20131672 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/cen.13811","volume":"89","author":"M Calanchini","year":"2018","unstructured":"Calanchini, M. et al. Liver biochemical abnormalities in Turner syndrome: a comprehensive characterization of an adult population. Clin. Endocrinol. 89, 667\u2013676 (2018).","journal-title":"Clin. Endocrinol."},{"key":"224_CR42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ajmg.a.37425","volume":"170","author":"RT Hamza","year":"2016","unstructured":"Hamza, R. T. et al. Renal anomalies in patients with Turner syndrome: is scintigraphy superior to ultrasound? Am. J. Med. Genet. A 170, 355\u2013362 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"224_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anorl.2017.08.006","volume":"135","author":"E Bois","year":"2018","unstructured":"Bois, E. et al. Otologic disorders in Turner syndrome. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 135, 21\u201324 (2018).","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"224_CR44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000363642","volume":"27","author":"M Cools","year":"2014","unstructured":"Cools, M., Looijenga, L. H., Wolffenbuttel, K. P. &\u00a0T\u2019Sjoen, G. Managing the risk of germ cell tumourigenesis in disorders of sex development patients. Endocr. Dev. 27, 185\u2013196 (2014).","journal-title":"Endocr. Dev."},{"key":"224_CR45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000484880","volume":"11","author":"A Rojek","year":"2017","unstructured":"Rojek, A., Obara-Moszynska, M., Kolesinska, Z., Rabska-Pietrzak, B. & Niedziela, M. Molecular detection and incidence of Y chromosomal material in\u00a0patients with Turner syndrome. Sex. Dev. 11, 254\u2013261 (2017).","journal-title":"Sex. Dev."},{"key":"224_CR46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ar.1091550309","volume":"155","author":"RP Singh","year":"1966","unstructured":"Singh, R. P. & Carr, D. H. The anatomy and histology of XO human embryos and fetuses. Anat. Rec. 155, 369\u2013383 (1966).","journal-title":"Anat. Rec."},{"key":"224_CR47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1297\/cpe.24.167","volume":"24","author":"T Tanaka","year":"2015","unstructured":"Tanaka, T. et al. Frequencies of spontaneous breast development and spontaneous menarche in Turner syndrome in Japan. Clin. Pediatr. Endocrinol. 24, 167\u2013173 (2015).","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"224_CR48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1590\/S0004-27302012000900009","volume":"56","author":"S Carpini","year":"2012","unstructured":"Carpini, S. et al. Spontaneous puberty in girls with early diagnosis of Turner syndrome. Arq. Bras. Endocrinol. Metabol. 56, 653\u2013657 (2012).","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"224_CR49","first-page":"1810","volume":"82","author":"AM Pasquino","year":"1997","unstructured":"Pasquino, A. M., Passeri, F., Pucarelli, I., Segni, M. & Municchi, G. Spontaneous pubertal development in Turner\u2019s syndrome. Italian Study Group for Turner\u2019s Syndrome. J. Clin. Endocrinol. Metab. 82, 1810\u20131813 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jc.2008-0708","volume":"94","author":"B Borgstrom","year":"2009","unstructured":"Borgstrom, B. et al. Fertility preservation in girls with Turner syndrome: prognostic signs of the presence of ovarian follicles. J. Clin. Endocrinol. Metab. 94, 74\u201380 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1399-0004.2002.610107.x","volume":"61","author":"N Birkebaek","year":"2002","unstructured":"Birkebaek, N., Cruger, D., Hansen, J., Nielsen, J. & Bruun-Petersen, G. Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin. Genet. 61, 35\u201339 (2002).","journal-title":"Clin. Genet."},{"key":"224_CR52","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/humrep\/dew012","volume":"31","author":"V Bernard","year":"2016","unstructured":"Bernard, V. et al. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum. Reprod. 31, 782\u2013788 (2016).","journal-title":"Hum. Reprod."},{"key":"224_CR53","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.fertnstert.2010.12.039","volume":"95","author":"I Bryman","year":"2011","unstructured":"Bryman, I. et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil. Steril. 95, 2507\u20132510 (2011).","journal-title":"Fertil. Steril."},{"key":"224_CR54","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/AOG.0b013e3181cb5b2a","volume":"115","author":"KH Mortensen","year":"2010","unstructured":"Mortensen, K. H., Rohde, M. D., Uldbjerg, N. & Gravholt, C. H. Repeated spontaneous pregnancies in\u00a045,X Turner syndrome. Obstet. Gynecol. 115, 446\u2013449 (2010).","journal-title":"Obstet. Gynecol."},{"key":"224_CR55","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/humrep\/14.2.532","volume":"14","author":"T Foudila","year":"1999","unstructured":"Foudila, T., S\u00f6derstr\u00f6m-Anttila, V. & Hovatta, O. Turner\u2019s syndrome and pregnancies after oocyte donation. Hum. Reprod. 14, 532\u2013535 (1999).","journal-title":"Hum. Reprod."},{"key":"224_CR56","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.fertnstert.2005.01.008","volume":"83","author":"Practice Committee of the American Society for Reproductive Medicine.","year":"2005","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in\u00a0women with Turner syndrome. Fertil. Steril. 83, 1074\u20131075 (2005).","journal-title":"Fertil. Steril."},{"key":"224_CR57","doi-asserted-by":"crossref","first-page":"E260","DOI":"10.1210\/jc.2010-0925","volume":"96","author":"N Chevalier","year":"2011","unstructured":"Chevalier, N. et al. Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and\u00a0pregnancy follow-up are associated with poor outcome. J. Clin. Endocrinol. Metab. 96, E260\u2013E267 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR58","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/humrep\/det113","volume":"28","author":"A Hagman","year":"2013","unstructured":"Hagman, A. et al. Morbidity and mortality after childbirth in women with Turner karyotype. Hum.\u00a0Reprod. 28, 1961\u20131973 (2013).","journal-title":"Hum. Reprod."},{"key":"224_CR59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejogrb.2018.08.005","volume":"229","author":"F Cadoret","year":"2018","unstructured":"Cadoret, F. et al. Pregnancy outcome in Turner syndrome: a French multi-center study after the 2009 guidelines. Eur. J. Obstet. Gynecol. Reprod. Biol. 229, 20\u201325 (2018).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"224_CR60","first-page":"484","volume":"208","author":"C Ros","year":"2013","unstructured":"Ros, C., Alobid, I., Balasch, J., Mullol, J. & Castelo-Branco, C. Turner\u2019s syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. Am. J. Obstet. Gynecol. 208, 484\u2013486 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"224_CR61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/jwh.2007.0488","volume":"17","author":"AT Sheaffer","year":"2008","unstructured":"Sheaffer, A. T., Lange, E. & Bondy, C. A. Sexual function in women with Turner syndrome. J. Womens Health 17, 27\u201333 (2008).","journal-title":"J. Womens Health"},{"key":"224_CR62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.1.02267","volume":"155","author":"CH Gravholt","year":"2006","unstructured":"Gravholt, C. H. et al. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur. J. Endocrinol. 155, 583\u2013592 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"224_CR63","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1096-8628(19971112)72:4<403::AID-AJMG6>3.0.CO;2-R","volume":"72","author":"CH Gravholt","year":"1997","unstructured":"Gravholt, C. H. & Naeraa, R. W. Reference values for\u00a0body proportions and body composition in adult women with Turner\u2019s syndrome. Am. J. Med. Genet. 72, 403\u2013408 (1997).","journal-title":"Am. J. Med. Genet."},{"key":"224_CR64","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1210\/jc.2007-2266","volume":"93","author":"N Wooten","year":"2008","unstructured":"Wooten, N., Bakalov, V. K., Hill, S. & Bondy, C. A. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J. Clin. Endocrinol. Metab. 93, 2109\u20132114 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR65","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1542\/peds.110.5.889","volume":"110","author":"CH Gravholt","year":"2002","unstructured":"Gravholt, C. H. et al. Short term growth hormone treatment in girls with Turner syndrome decreases fat\u00a0mass and insulin sensitivity. A randomized double-blind, placebo-controlled cross-over study. Pediatrics 110, 889\u2013896 (2002).","journal-title":"Pediatrics"},{"key":"224_CR66","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/diacare.21.7.1062","volume":"21","author":"CH Gravholt","year":"1998","unstructured":"Gravholt, C. H. et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner\u2019s syndrome. The impact of sex hormone replacement. Diabetes Care 21, 1062\u20131070 (1998).","journal-title":"Diabetes Care"},{"key":"224_CR67","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1210\/jc.2011-1449","volume":"96","author":"M Taboada","year":"2011","unstructured":"Taboada, M. et al. Pharmacokinetics and pharmacodynamics of oral and transdermal 17\u03b2 estradiol in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 96, 3502\u20133510 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/met.2013.0075","volume":"12","author":"V Calcaterra","year":"2014","unstructured":"Calcaterra, V. et al. Metabolic syndrome in Turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics. Metab. Syndr. Relat. Disord. 12, 159\u2013164 (2014).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"224_CR69","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1210\/jcem.86.9.7818","volume":"86","author":"K Landin-Wilhelmsen","year":"2001","unstructured":"Landin-Wilhelmsen, K., Bryman, I. & Wilhelmsen, L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J. Clin. Endocrinol. Metab. 86, 4166\u20134170 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0021-9150(99)00369-X","volume":"150","author":"CH Gravholt","year":"2000","unstructured":"Gravholt, C. H., Klausen, I. C., Weeke, J. & Christiansen, J. S. Lp(a) and lipids in adult Turner\u2019s syndrome: impact of treatment with 17\u03b2-estradiol and\u00a0norethisterone. Atherosclerosis 150, 201\u2013208 (2000).","journal-title":"Atherosclerosis"},{"key":"224_CR71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(95)70551-1","volume":"126","author":"JL Ross","year":"1995","unstructured":"Ross, J. L. et al. Lipid abnormalities in Turner syndrome. J. Pediatr. 126, 242\u2013245 (1995).","journal-title":"J. Pediatr."},{"key":"224_CR72","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1210\/jc.2006-0503","volume":"91","author":"PL Van","year":"2006","unstructured":"Van, P. L., Bakalov, V. K. & Bondy, C. A. Monosomy for the X-chromosome is associated with an atherogenic lipid profile. J. Clin. Endocrinol. Metab. 91, 2867\u20132870 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR73","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/HYPERTENSIONAHA.118.11742","volume":"73","author":"S Brun","year":"2019","unstructured":"Brun, S. et al. Five-year randomized study demonstrates blood pressure increases in young women with Turner syndrome regardless of estradiol dose. Hypertension 73, 242\u2013248 (2019).","journal-title":"Hypertension"},{"key":"224_CR74","doi-asserted-by":"crossref","first-page":"E1517","DOI":"10.1210\/jc.2011-0346","volume":"96","author":"K Freriks","year":"2011","unstructured":"Freriks, K. et al. Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. J.\u00a0Clin. Endocrinol. Metab. 96, E1517\u2013E1526 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR75","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6823-11-6","volume":"11","author":"BE Hjerrild","year":"2011","unstructured":"Hjerrild, B. E. et al. Delayed \u03b2-cell response and glucose intolerance in young women with Turner syndrome. BMC Endocr. Disord. 11, 6 (2011).","journal-title":"BMC Endocr. Disord."},{"key":"224_CR76","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1210\/jc.2004-0122","volume":"89","author":"VK Bakalov","year":"2004","unstructured":"Bakalov, V. K. et al. Impaired insulin secretion in the Turner metabolic syndrome. J. Clin. Endocrinol. Metab. 89, 3516\u20133520 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fendo.2019.00049","volume":"10","author":"L Sun","year":"2019","unstructured":"Sun, L. et al. Glucose metabolism in Turner syndrome. Front. Endocrinol. 10, 49 (2019).","journal-title":"Front. Endocrinol."},{"key":"224_CR78","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/jc.2009-0384","volume":"94","author":"VK Bakalov","year":"2009","unstructured":"Bakalov, V. K., Cheng, C., Zhou, J. & Bondy, C. A. X-chromosome gene dosage and the risk of diabetes in Turner syndrome. J. Clin. Endocrinol. Metab. 94, 3289\u20133296 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR79","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11154-008-9076-2","volume":"9","author":"VK Bakalov","year":"2008","unstructured":"Bakalov, V. K. & Bondy, C. A. Fracture risk and bone mineral density in Turner syndrome. Rev. Endocr. Metab. Disord. 9, 145\u2013151 (2008).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"224_CR80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2265.2003.01807.x","volume":"59","author":"CH Gravholt","year":"2003","unstructured":"Gravholt, C. H. et al. Increased fracture rates in Turner\u2019s syndrome: a nationwide questionnaire survey. Clin. Endocrinol. 59, 89\u201396 (2003).","journal-title":"Clin. Endocrinol."},{"key":"224_CR81","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2265.1999.00841.x","volume":"51","author":"K Landin-Wilhelmsen","year":"1999","unstructured":"Landin-Wilhelmsen, K., Bryman, I., Windh, M. & Wilhelmsen, L. Osteoporosis and fractures in Turner syndrome\u2013importance of growth promoting and oestrogen therapy. Clin. Endocrinol. 51, 497\u2013502 (1999).","journal-title":"Clin. Endocrinol."},{"key":"224_CR82","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0002-9343(03)00364-4","volume":"115","author":"VK Bakalov","year":"2003","unstructured":"Bakalov, V. K. et al. Bone mineral density and fractures in Turner syndrome. Am. J. Med. 115, 259\u2013264 (2003).","journal-title":"Am. J. Med."},{"key":"224_CR83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jcem-73-2-355","volume":"73","author":"JL Ross","year":"1991","unstructured":"Ross, J. L., Long, L. M., Feuillan, P., Cassorla, F. & Cutler, G. B. J. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner\u2019s syndrome. J. Clin. Endocrinol. Metab. 73, 355\u2013359 (1991).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR84","volume":"6","author":"K Shi","year":"2016","unstructured":"Shi, K. et al. Body composition and bone mineral status in patients with Turner syndrome. Sci. Rep. 6, 38026 (2016).","journal-title":"Sci. Rep."},{"key":"224_CR85","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00198-010-1170-0","volume":"21","author":"CR Holroyd","year":"2010","unstructured":"Holroyd, C. R. et al. Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome. Osteoporos. Int. 21, 2093\u20132099 (2010).","journal-title":"Osteoporos. Int."},{"key":"224_CR86","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/jbmr.1624","volume":"27","author":"S Hansen","year":"2012","unstructured":"Hansen, S., Brixen, K. & Gravholt, C. H. Compromised trabecular microarchitecture and lower finite element estimates of radius and tibia bone strength in adults with Turner syndrome: a cross-sectional study using high-resolution-pQCT. J. Bone Miner. Res. 27, 1794\u20131803 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"224_CR87","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1359\/jbmr.2000.15.10.2005","volume":"15","author":"A Carrascosa","year":"2000","unstructured":"Carrascosa, A. et al. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J. Bone Miner. Res. 15, 2005\u20132010 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"224_CR88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-09-0020","volume":"161","author":"L Cleemann","year":"2009","unstructured":"Cleemann, L. et al. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. Eur. J. Endocrinol. 161, 251\u2013257 (2009).","journal-title":"Eur. J. Endocrinol."},{"key":"224_CR89","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/13697137.2017.1325461","volume":"20","author":"HH Nguyen","year":"2017","unstructured":"Nguyen, H. H. et al. Delay in estrogen commencement is associated with lower bone mineral density in Turner syndrome. Climacteric 20, 436\u2013441 (2017).","journal-title":"Climacteric"},{"key":"224_CR90","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/154099903322643893","volume":"12","author":"L Hanton","year":"2003","unstructured":"Hanton, L., Axelrod, L., Bakalov, V. & Bondy, C. A. The\u00a0importance of estrogen replacement in young women with Turner syndrome. J. Womens Health 12, 971\u2013977 (2003).","journal-title":"J. Womens Health"},{"key":"224_CR91","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.27270","volume":"62","author":"KT Jorgensen","year":"2010","unstructured":"Jorgensen, K. T. et al. Autoimmune diseases in women with Turner\u2019s syndrome. Arthritis Rheum. 62, 658\u2013666 (2010).","journal-title":"Arthritis Rheum."},{"key":"224_CR92","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2232","volume":"137","author":"K Marild","year":"2016","unstructured":"Marild, K., Stordal, K., Hagman, A. & Ludvigsson, J. F. Turner syndrome and celiac disease: a case-control study. Pediatrics 137, e20152232 (2016).","journal-title":"Pediatrics"},{"key":"224_CR93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2249.2009.03895.x","volume":"156","author":"KH Mortensen","year":"2009","unstructured":"Mortensen, K. H. et al. Increased prevalence of autoimmunity in Turner syndrome\u2014influence of\u00a0age.\u00a0Clin. Exp. Immunol. 156, 205\u2013210 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"224_CR94","volume":"11","author":"SOO Mohamed","year":"2018","unstructured":"Mohamed, S. O. O. et al. Prevalence of autoimmune thyroid diseases among the Turner Syndrome patients: meta-analysis of cross sectional studies. BMC Res. Notes 11, 842 (2018).","journal-title":"BMC Res. Notes"},{"key":"224_CR95","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1210\/jc.2004-1262","volume":"90","author":"M El Mansoury","year":"2005","unstructured":"El Mansoury, M. et al. Hypothyroidism is common in\u00a0Turner syndrome: results of a five-year follow-up. J.\u00a0Clin. Endocrinol. Metab. 90, 2131\u20132135 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR96","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaut.2012.01.015","volume":"38","author":"VK Bakalov","year":"2012","unstructured":"Bakalov, V. K. et al. Autoimmune disorders in women with Turner syndrome and women with karyotypically normal primary ovarian insufficiency. J. Autoimmun. 38, 315\u2013321 (2012).","journal-title":"J. Autoimmun."},{"key":"224_CR97","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2265.2001.01296.x","volume":"55","author":"M Elsheikh","year":"2001","unstructured":"Elsheikh, M., Wass, J. A. & Conway, G. S. Autoimmune thyroid syndrome in women with Turner\u2019s syndrome \u2014 the association with karyotype. Clin. Endocrinol. 55, 223\u2013226 (2001).","journal-title":"Clin. Endocrinol."},{"key":"224_CR98","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2815","volume":"10","author":"C Libert","year":"2010","unstructured":"Libert, C., Dejager, L. & Pinheiro, I. The X chromosome in immune functions: when a chromosome makes the difference. Nat. Rev. Immunol. 10, 594\u2013604 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"224_CR99","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2009.03.002","volume":"33","author":"D Larizza","year":"2009","unstructured":"Larizza, D., Calcaterra, V. & Martinetti, M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J. Autoimmun. 33, 25\u201330 (2009).","journal-title":"J. Autoimmun."},{"key":"224_CR100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fendo.2018.00307","volume":"9","author":"AM Gawlik","year":"2018","unstructured":"Gawlik, A. M. et al. Immunological profile and predisposition to autoimmunity in girls with Turner syndrome. Front. Endocrinol. 9, 307 (2018).","journal-title":"Front. Endocrinol."},{"key":"224_CR101","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.175.1.575","volume":"175","author":"P Invernizzi","year":"2005","unstructured":"Invernizzi, P. et al. X chromosome monosomy: a\u00a0common mechanism for autoimmune diseases. J.\u00a0Immunol. 175, 575\u2013578 (2005).","journal-title":"J. Immunol."},{"key":"224_CR102","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2007.03166.x","volume":"68","author":"M El-Mansoury","year":"2008","unstructured":"El-Mansoury, M. et al. Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clin.\u00a0Endocrinol. 68, 485\u2013490 (2008).","journal-title":"Clin. Endocrinol."},{"key":"224_CR103","first-page":"2570","volume":"82","author":"CH Gravholt","year":"1997","unstructured":"Gravholt, C. H., Naeraa, R. W., Fisker, S. & Christiansen, J. S. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth axis aberrations in adult Turner\u2019s syndrome, with important modulations by treatment with 17\u03b2-estradiol. J. Clin. Endocrinol. Metab. 82, 2570\u20132577 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR104","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.20026","volume":"39","author":"D Roulot","year":"2004","unstructured":"Roulot, D. et al. Vascular involvement of the liver in Turner\u2019s syndrome. Hepatology 39, 239\u2013247 (2004).","journal-title":"Hepatology"},{"key":"224_CR105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2265.2001.01321.x","volume":"55","author":"M Elsheikh","year":"2001","unstructured":"Elsheikh, M., Hodgson, H. J., Wass, J. A. & Conway, G. S. Hormone replacement therapy may improve hepatic function in women with Turner\u2019s syndrome. Clin. Endocrinol. 55, 227\u2013231 (2001).","journal-title":"Clin. Endocrinol."},{"key":"224_CR106","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-07-0070","volume":"156","author":"CH Gravholt","year":"2007","unstructured":"Gravholt, C. H., Poulsen, H. E., Ott, P., Christiansen, J. S. & Vilstrup, H. Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. Eur. J. Endocrinol. 156, 679\u2013686 (2007).","journal-title":"Eur. J. Endocrinol."},{"key":"224_CR107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jjcc.2016.03.006","volume":"69","author":"K De Groote","year":"2017","unstructured":"De Groote, K. et al. Increased aortic stiffness in prepubertal girls with Turner syndrome. J. Cardiol. 69, 201\u2013207 (2017).","journal-title":"J. Cardiol."},{"key":"224_CR108","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/jpem-2016-0301","volume":"30","author":"E Klaskova","year":"2017","unstructured":"Klaskova, E. et al. Increased prevalence of bicuspid aortic valve in Turner syndrome links with karyotype: the crucial importance of detailed cardiovascular screening. J. Pediatr. Endocrinol. Metab. 30, 319\u2013325 (2017).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"224_CR109","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1017\/S1047951115002735","volume":"26","author":"KH Mortensen","year":"2016","unstructured":"Mortensen, K. H., Gopalan, D., Norgaard, B. L., Andersen, N. H. & Gravholt, C. H. Multimodality cardiac imaging in Turner syndrome. Cardiol. Young 26, 831\u2013841 (2016).","journal-title":"Cardiol. Young"},{"key":"224_CR110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jcct.2016.08.004","volume":"10","author":"MH Viuff","year":"2016","unstructured":"Viuff, M. H. et al. Coronary artery anomalies in Turner syndrome. J. Cardiovasc. Comput. Tomogr. 10, 480\u2013484 (2016).","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"224_CR111","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/heartjnl-2017-312658","volume":"104","author":"KH Mortensen","year":"2018","unstructured":"Mortensen, K. H. et al. Cardiovascular imaging in Turner syndrome: state-of-the-art practice across the lifespan. Heart 104, 1823\u20131831 (2018).","journal-title":"Heart"},{"key":"224_CR112","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/01.CIR.0000142290.35842.B0","volume":"110","author":"VB Ho","year":"2004","unstructured":"Ho, V. B. et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110, 1694\u20131700 (2004).","journal-title":"Circulation"},{"key":"224_CR113","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.amjcard.2018.03.357","volume":"122","author":"AT Yetman","year":"2018","unstructured":"Yetman, A. T. et al. Clinical and echocardiographic prevalence and detection of congenital and acquired cardiac abnormalities in girls and women with the Turner syndrome. Am. J. Cardiol. 122, 327\u2013330 (2018).","journal-title":"Am. J. Cardiol."},{"key":"224_CR114","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1469-0705.2002.00739.x","volume":"20","author":"MC Haak","year":"2002","unstructured":"Haak, M. C., Bartelings, M. M., Gittenberger-De Groot, A. C. & van Vugt, J. M. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology. Ultrasound Obstet. Gynecol. 20, 14\u201321 (2002).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"224_CR115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/chd.12413","volume":"12","author":"DA Lara","year":"2017","unstructured":"Lara, D. A., Ethen, M. K., Canfield, M. A., Nembhard, W. N. & Morris, S. A. A population-based analysis of mortality in patients with Turner syndrome and hypoplastic left heart syndrome using the Texas Birth Defects Registry. Congenit. Heart Dis. 12, 105\u2013112 (2017).","journal-title":"Congenit. Heart Dis."},{"key":"224_CR116","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00246-017-1801-8","volume":"39","author":"JD Chew","year":"2018","unstructured":"Chew, J. D. et al. Heart transplantation in children with Turner syndrome: analysis of a linked dataset. Pediatr. Cardiol. 39, 610\u2013616 (2018).","journal-title":"Pediatr. Cardiol."},{"key":"224_CR117","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/CIRCULATIONAHA.106.685487","volume":"116","author":"LA Matura","year":"2007","unstructured":"Matura, L. A., Ho, V. B., Rosing, D. R. & Bondy, C. A. Aortic dilatation and dissection in Turner syndrome. Circulation 116, 1663\u20131670 (2007).","journal-title":"Circulation"},{"key":"224_CR118","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jez065","author":"KH Mortensen","year":"2019","unstructured":"Mortensen, K. H. et al. Aortic growth rates are not increased in Turner syndrome \u2014 a prospective CMR study. Eur. Heart J. Cardiovasc. Imaging https:\/\/doi.org\/10.1093\/ehjci\/jez065 (2019).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"224_CR119","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1532-429X-15-47","volume":"15","author":"KH Mortensen","year":"2013","unstructured":"Mortensen, K. H., Erlandsen, M., Andersen, N. H. & Gravholt, C. H. Prediction of aortic dilation in Turner syndrome \u2014 enhancing the use of serial cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 15, 47 (2013).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"224_CR120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12968-017-0336-8","volume":"19","author":"DR Subramaniam","year":"2017","unstructured":"Subramaniam, D. R. et al. Continuous measurement of aortic dimensions in Turner syndrome: a\u00a0cardiovascular magnetic resonance study. J.\u00a0Cardiovasc. Magn. Reson. 19, 20 (2017).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"224_CR121","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2265.2012.04337.x","volume":"77","author":"KH Mortensen","year":"2012","unstructured":"Mortensen, K. H. et al. Carotid intima-media thickness is increased in Turner syndrome: multifactorial pathogenesis depending on age, blood pressure, cholesterol and oestrogen treatment. Clin. Endocrinol. 77, 844\u2013851 (2012).","journal-title":"Clin. Endocrinol."},{"key":"224_CR122","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/gim.2017.149","volume":"20","author":"M Schoepp","year":"2017","unstructured":"Schoepp, M. et al. Coronary calcification in adults with Turner syndrome. Genet. Med. 20, 664\u2013668 (2017).","journal-title":"Genet. Med."},{"key":"224_CR123","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-015-0288-8","volume":"10","author":"JN Schouten","year":"2015","unstructured":"Schouten, J. N., Verheij, J. & Seijo, S. Idiopathic non-cirrhotic portal hypertension: a review. Orphanet J. Rare Dis. 10, 67 (2015).","journal-title":"Orphanet J. Rare Dis."},{"key":"224_CR124","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2265.2011.04190.x","volume":"76","author":"CH Gravholt","year":"2012","unstructured":"Gravholt, C. H. et al. Coagulation and fibrinolytic disturbances are related to carotid intima thickness and arterial blood pressure in Turner syndrome. Clin.\u00a0Endocrinol. 76, 649\u2013656 (2012).","journal-title":"Clin. Endocrinol."},{"key":"224_CR125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1017\/S1047951106000928","volume":"16","author":"CH Gravholt","year":"2006","unstructured":"Gravholt, C. H. et al. Clinical and epidemiological description of aortic dissection in Turner\u2019s syndrome. Cardiol. Young 16, 430\u2013436 (2006).","journal-title":"Cardiol. Young"},{"key":"224_CR126","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/CIRCULATIONAHA.111.088633","volume":"126","author":"M Carlson","year":"2012","unstructured":"Carlson, M., Airhart, N., Lopez, L. & Silberbach, M. Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: report of the International Turner Syndrome Aortic Dissection Registry. Circulation 126, 2220\u20132226 (2012).","journal-title":"Circulation"},{"key":"224_CR127","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jmg.2007.052019","volume":"44","author":"M Carlson","year":"2007","unstructured":"Carlson, M. & Silberbach, M. Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in\u00a0the literature. J. Med. Genet. 44, 745\u2013749 (2007).","journal-title":"J. Med. Genet."},{"key":"224_CR128","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00380-014-0529-0","volume":"30","author":"K De Groote","year":"2014","unstructured":"De Groote, K. et al. Abnormal aortic arch morphology in Turner syndrome patients is a risk factor for hypertension. Heart Vessels 30, 618\u2013625 (2014).","journal-title":"Heart Vessels"},{"key":"224_CR129","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/archdischild-2014-307080","volume":"100","author":"EJ Turtle","year":"2015","unstructured":"Turtle, E. J., Sule, A. A., Webb, D. J. & Bath, L. E. Aortic dissection in children and adolescents with Turner syndrome: risk factors and management recommendations. Arch. Dis. Child. 100, 662\u2013666 (2015).","journal-title":"Arch. Dis. Child."},{"key":"224_CR130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2265.2000.00960.x","volume":"52","author":"NC Nathwani","year":"2000","unstructured":"Nathwani, N. C., Unwin, R., Brook, C. G. & Hindmarsh, P. C. Blood pressure and Turner syndrome. Clin. Endocrinol. 52, 363\u2013370 (2000).","journal-title":"Clin. Endocrinol."},{"key":"224_CR131","doi-asserted-by":"crossref","first-page":"e1622","DOI":"10.1542\/peds.2007-2807","volume":"121","author":"L Lopez","year":"2008","unstructured":"Lopez, L. et al. Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics 121, e1622\u2013e1627 (2008).","journal-title":"Pediatrics"},{"key":"224_CR132","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2265.2001.01154.x","volume":"54","author":"M Elsheikh","year":"2001","unstructured":"Elsheikh, M., Casadei, B., Conway, G. S. & Wass, J. A. Hypertension is a major risk factor for aortic root dilatation in women with Turner\u2019s syndrome. Clin.\u00a0Endocrinol. 54, 69\u201373 (2001).","journal-title":"Clin. Endocrinol."},{"key":"224_CR133","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-12-12","volume":"12","author":"BE Hjerrild","year":"2010","unstructured":"Hjerrild, B. E. et al. Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study. J. Cardiovasc. Magn. Res. 12, 12 (2010).","journal-title":"J. Cardiovasc. Magn. Res."},{"key":"224_CR134","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/HYPERTENSIONAHA.108.126516","volume":"53","author":"JP Langrish","year":"2009","unstructured":"Langrish, J. P. et al. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 53, 805\u2013811 (2009).","journal-title":"Hypertension"},{"key":"224_CR135","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/HJH.0000000000000599","volume":"33","author":"K De Groote","year":"2015","unstructured":"De Groote, K. et al. Arterial hypertension in Turner syndrome: a review of the literature and a practical approach for diagnosis and treatment. J. Hypertens. 33, 1342\u20131351 (2015).","journal-title":"J. Hypertens."},{"key":"224_CR136","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2265.2006.02483.x","volume":"64","author":"N Zuckerman-Levin","year":"2006","unstructured":"Zuckerman-Levin, N. et al. Physiological and catecholamine response to sympathetic stimulation in Turner syndrome. Clin. Endocrinol. 64, 410\u2013415 (2006).","journal-title":"Clin. Endocrinol."},{"key":"224_CR137","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.hjh.0000200509.17947.0f","volume":"24","author":"CH Gravholt","year":"2006","unstructured":"Gravholt, C. H., Hansen, K. W., Erlandsen, M., Ebbehoj, E. & Christiansen, J. S. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J. Hypertens. 24, 353\u2013360 (2006).","journal-title":"J. Hypertens."},{"key":"224_CR138","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1747-0803.2011.00575.x","volume":"6","author":"TA Pedersen","year":"2011","unstructured":"Pedersen, T. A. et al. High long-term morbidity in repaired aortic coarctation: weak association with residual arch obstruction. Congenit. Heart Dis. 6, 573\u2013582 (2011).","journal-title":"Congenit. Heart Dis."},{"key":"224_CR139","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/hrt.2004.048371","volume":"91","author":"JP Baguet","year":"2005","unstructured":"Baguet, J. P. et al. Structural and functional abnormalities of large arteries in the Turner syndrome. Heart 91, 1442\u20131446 (2005).","journal-title":"Heart"},{"key":"224_CR140","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1540-8175.2009.00902.x","volume":"26","author":"AB Sozen","year":"2009","unstructured":"Sozen, A. B. et al. Left ventricular thickness is increased in nonhypertensive Turner\u2019s syndrome. Echocardiography 26, 943\u2013949 (2009).","journal-title":"Echocardiography"},{"key":"224_CR141","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cen.12720","volume":"83","author":"C Trolle","year":"2015","unstructured":"Trolle, C. et al. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study. Clin. Endocrinol. 83, 133\u2013140 (2015).","journal-title":"Clin. Endocrinol."},{"key":"224_CR142","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/hrt.2005.081471","volume":"92","author":"NH Andersen","year":"2006","unstructured":"Andersen, N. H. et al. Subclinical left ventricle dysfunction in normotensive women with Turner\u2019s syndrome. Heart 92, 1516\u20131517 (2006).","journal-title":"Heart"},{"key":"224_CR143","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12968-017-0331-0","volume":"19","author":"DG Devos","year":"2017","unstructured":"Devos, D. G. et al. Proximal aortic stiffening in Turner patients may be present before dilation can be detected: a segmental functional MRI study. J.\u00a0Cardiovasc. Magn. Reson. 19, 27 (2017).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"224_CR144","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1210\/jc.2004-1939","volume":"90","author":"JE Ostberg","year":"2005","unstructured":"Ostberg, J. E. et al. Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J. Clin. Endocrinol. Metab. 90, 2631\u20132635 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1474-4422(13)70302-8","volume":"13","author":"DS Hong","year":"2014","unstructured":"Hong, D. S. & Reiss, A. L. Cognitive and neurological aspects of sex chromosome aneuploidies. Lancet Neurol. 13, 306\u2013318 (2014).","journal-title":"Lancet Neurol."},{"key":"224_CR146","doi-asserted-by":"crossref","first-page":"229","DOI":"10.17219\/acem\/66986","volume":"27","author":"W Jez","year":"2018","unstructured":"Jez, W. et al. Social and medical determinants of quality of life and life satisfaction in women with Turner syndrome. Adv. Clin. Exp. Med. 27, 229\u2013236 (2018).","journal-title":"Adv. Clin. Exp. Med."},{"key":"224_CR147","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-3342-0","volume":"18","author":"U Thyen","year":"2018","unstructured":"Thyen, U. et al. Quality of health care in adolescents and adults with disorders\/differences of sex development (DSD) in six European countries (dsd-LIFE). BMC Health Serv. Res. 18, 527 (2018).","journal-title":"BMC Health Serv. Res."},{"key":"224_CR148","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/YCO.0000000000000472","volume":"32","author":"J Wolstencroft","year":"2018","unstructured":"Wolstencroft, J. & Skuse, D. Social skills and relationships in Turner syndrome. Curr. Opin. Psychiatry 32, 85\u201391 (2018).","journal-title":"Curr. Opin. Psychiatry"},{"key":"224_CR149","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s11136-018-1810-y","volume":"27","author":"CT Reis","year":"2018","unstructured":"Reis, C. T., de Assumpcao, M. S., Guerra-Junior, G. & de Lemos-Marini, S. H. V. Systematic review of quality of life in Turner syndrome. Qual. Life Res. 27, 1985\u20132006 (2018).","journal-title":"Qual. Life Res."},{"key":"224_CR150","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1210\/jc.2002-021171","volume":"88","author":"YK Van Pareren","year":"2003","unstructured":"Van Pareren, Y. K. et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J. Clin. Endocrinol. Metab. 88, 1119\u20131125 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR151","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1530\/EC-18-0115","volume":"7","author":"P Li","year":"2018","unstructured":"Li, P., Cheng, F. & Xiu, L. Height outcome of the recombinant human growth hormone treatment in Turner syndrome: a meta-analysis. Endocr. Connect. 7, 573\u2013583 (2018).","journal-title":"Endocr. Connect."},{"key":"224_CR152","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1210\/jc.2017-00214","volume":"102","author":"CA Quigley","year":"2017","unstructured":"Quigley, C. A. et al. Mortality in children receiving growth hormone treatment of growth disorders: data from the Genetics and Neuroendocrinology of Short Stature International Study. J. Clin. Endocrinol. Metab. 102, 3195\u20133205 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR153","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1210\/jc.2017-02183","volume":"103","author":"KO Klein","year":"2018","unstructured":"Klein, K. O. et al. Estrogen replacement in Turner\u00a0syndrome: literature review and practical considerations. J. Clin. Endocrinol. Metab. 103, 1790\u20131803 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR154","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen.13869","volume":"90","author":"N Mauras","year":"2019","unstructured":"Mauras, N. et al. Impact of route of administration on genotoxic oestrogens concentrations using oral versus transdermal oestradiol in girls with Turner syndrome. Clin. Endocrinol. 90, 155\u2013161 (2019).","journal-title":"Clin. Endocrinol."},{"key":"224_CR155","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2265.2011.03995.x","volume":"74","author":"L Cleemann","year":"2011","unstructured":"Cleemann, L. et al. Uterus and ovaries in girls and young women with Turner syndrome evaluated by ultrasound and magnetic resonance imaging. Clin.\u00a0Endocrinol. 74, 756\u2013761 (2011).","journal-title":"Clin. Endocrinol."},{"key":"224_CR156","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2018.00023","volume":"9","author":"AM Gawlik","year":"2018","unstructured":"Gawlik, A. M. et al. Late-onset puberty induction by transdermal estrogen in Turner syndrome girls \u2014 a longitudinal study. Front. Endocrinol. 9, 23 (2018).","journal-title":"Front. Endocrinol."},{"key":"224_CR157","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2265.2008.03203.x","volume":"69","author":"O Koulouri","year":"2008","unstructured":"Koulouri, O., Ostberg, J. & Conway, G. S. Liver dysfunction in Turner\u2019s syndrome: prevalence, natural\u00a0history and effect of exogenous oestrogen. Clin. Endocrinol. 69, 306\u2013310 (2008).","journal-title":"Clin. Endocrinol."},{"key":"224_CR158","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-16-0582","volume":"176","author":"L Cleemann","year":"2017","unstructured":"Cleemann, L. et al. Dosage of estradiol, bone and body composition in Turner syndrome: a 5-year randomized controlled clinical trial. Eur. J. Endocrinol. 176, 233\u2013242 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"224_CR159","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(96)90075-6","volume":"347","author":"YT van der Schouw","year":"1996","unstructured":"van der Schouw, Y. T., van der, G. Y., Steyerberg, E. W., Eijkemans, J. C. & Banga, J. D. Age at menopause as a risk factor for cardiovascular mortality. Lancet 347, 714\u2013718 (1996).","journal-title":"Lancet"},{"key":"224_CR160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/gme.0b013e31822a9937","volume":"19","author":"WA Rocca","year":"2012","unstructured":"Rocca, W. A., Grossardt, B. R., Miller, V. M., Shuster, L. T. & Brown, R. D. Jr. Premature menopause or early menopause and risk of ischemic stroke. Menopause 19, 272\u2013277 (2012).","journal-title":"Menopause"},{"key":"224_CR161","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12020-016-1046-y","volume":"55","author":"D Cintron","year":"2016","unstructured":"Cintron, D. et al. Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with Turner syndrome: a systematic review and meta-analysis. Endocrine 55, 366\u2013375 (2016).","journal-title":"Endocrine"},{"key":"224_CR162","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1210\/jc.2009-0514","volume":"94","author":"N Zuckerman-Levin","year":"2009","unstructured":"Zuckerman-Levin, N. et al. Androgen replacement therapy in Turner syndrome: a pilot study. J. Clin. Endocrinol. Metab. 94, 4820\u20134827 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR163","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1210\/jc.2009-0495","volume":"94","author":"M Devernay","year":"2009","unstructured":"Devernay, M., Ecosse, E., Coste, J. & Carel, J. C. Determinants of medical care for young women with Turner syndrome. J. Clin. Endocrinol. Metab. 94, 3408\u20133413 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"224_CR164","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/EJE-13-0900","volume":"170","author":"A Gawlik","year":"2013","unstructured":"Gawlik, A. & Malecka-Tendera, E. Transitions in endocrinology: treatment of Turner\u2019s syndrome during transition. Eur. J. Endocrinol. 170, R57\u2013R74 (2013).","journal-title":"Eur. J. Endocrinol."},{"key":"224_CR165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4158\/EP11059.OR","volume":"17","author":"ZM Nabhan","year":"2011","unstructured":"Nabhan, Z. M. & Eugster, E. A. Medical care of girls with Turner syndrome: where are we lacking? Endocr. Pract. 17, 747\u2013752 (2011).","journal-title":"Endocr. Pract."},{"key":"224_CR166","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1530\/EC-18-0053","volume":"7","author":"DA Ertl","year":"2018","unstructured":"Ertl, D. A. et al. Health status, quality of life and medical care in adult women with Turner syndrome. Endocr. Connect. 7, 534\u2013543 (2018).","journal-title":"Endocr. Connect."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0224-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:47:19Z","timestamp":1684604839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-019-0224-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,18]]},"references-count":166,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1038\/s41574-019-0224-4","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,18]]},"assertion":[{"value":"23 May 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}